Company Profile
Updated: 17-SEP-09Aventis Pharmaceuticals Inc.
Exporter
300 Somerset Corporate Blvd., Bridgewater, NJ 08807-2844, United States
(800)981-2491, (908)231-4000, (908)231-3614 fax, http://www.aventispharma-us.com
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Manufactures prescription and over the counter pharmaceuticals.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
CombinatoRx Reports Financial Results for the Third Quarter 2009.(Financial report)
Biotech Week; 11/18/2009; 1645 words; ...REMS program, Sanofi-Aventis' acquisition of Prednisporin...acquisition of Fovea Pharmaceuticals, and the presentation...Neuromed Pharmaceuticals Inc. The merger seeks to...acquired by Mallinckrodt Inc., a subsidiary of Covidien...key asset by Sanofi-Aventis in its pending ...
NovaDel Receives Notice of Allowance for New U.S. Patent Covering its Oral Spray Drug Delivery Technology.
Biotech Week; 11/18/2009; 1341 words; NovaDel Pharma Inc. (NYSE AMEX: NVD...also NovaDel Pharma Inc.). As previously...trademark of sanofi-aventis. ABOUT NOVADEL PHARMA NovaDel Pharma Inc. is a specialty pharmaceutical...Health, Biotechnology, Pharmaceutical, Other Health, Research...Patents Actions, Pharmaceuticals, ...
Emisphere Technologies Appoints Tim Rothwell to the Board of Directors.
Biotech Week; 11/18/2009; 985 words; ...Rhone-Poulenc Rorer Pharmaceuticals and President of the company's Global Pharmaceutical Operations. In his...Officer of Sandoz Pharmaceuticals, Vice President...Emisphere Technologies, Inc., Health, Biotechnology...Fitness and Nutrition, Pharmaceutical, Other ...
Accelrys Announces Second Quarter Fiscal Year 2010 Financial Results.(Financial report)
Biotech Week; 11/18/2009; 1270 words; ...also Accelrys, Inc.). "Year...companies outside the pharmaceutical industry by entering...specialty chemicals, pharmaceuticals, consumer packaged...from the leading pharmaceutical and manufacturing...Unilever and Sanofi-Aventis. Non-GAAP Financial...Keywords: Accelrys, Inc., ...
Thirteen Abstracts Featuring Exelixis Compounds Accepted for Presentation at the 2009 AACR-NCI-EORTC International Conference.(Conference news)
Cancer Weekly; 11/17/2009; 1618 words; Exelixis, Inc. (Nasdaq: EXEL) announced...collaboration with sanofi-aventis. Clinical data for an ongoing...About Exelixis Exelixis, Inc. is a development-stage...corporate alliances with major pharmaceutical and biotechnology companies...
Recent News Articles
- Zacks Analyst Blog Highlights: AMAG Pharmaceuticals Inc., Fresenius Medical Care AG & Co., Watson Pharmaceuticals, Inc., Sanofi-Aventis and ReneSola Ltd.
Business Wire - July 15, 2009 - Health Care Organizations Targeted With Anti-Fraud Enforcement Efforts: New And Ongoing Initiatives Will Affect Oversight Components Of Health Care Reform.(Fraud Enforcement and Recovery Act of 2009)(United States. Department of Health and Human Services)(United States. Department of Justice)(Aventis Pharmaceuticals Inc.)(Minnesota Hospitals)(Wyeth)
Mondaq Business Briefing - June 23, 2009 - Research and Markets: Pfizer Inc, GlaxoSmithKline Plc and Sanofi-Aventis Group Are Profiled Inside the Global Pharmaceuticals Industry Profile.
Business Wire - February 09, 2007 - Sanofi-Aventis wins Lovenox patent appeal.(against Amphastar Pharmaceuticals and Teva Pharmaceuticals USA Inc.)
Pharma Marketletter - April 17, 2006
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning